Endothelins are potent vasoconstrictors, and much more besides

This publication has 7 references indexed in Scilit:

• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
  Nature, 1999
• Isoforms of endothelin-converting enzyme: why and where?
  Trends in Pharmacological Sciences, 1998
• Short-Term Oral Endothelin-Receptor Antagonist Therapy in Conventionally Treated Patients With Symptomatic Severe Chronic Heart Failure
  Circulation, 1998
• Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease.
  Journal of Clinical Investigation, 1998
• The Effect of an Endothelin-Receptor Antagonist, Bosentan, on Blood Pressure in Patients with Essential Hypertension
  New England Journal of Medicine, 1998
• The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.
  Proceedings of the National Academy of Sciences, 1989
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells
  Nature, 1988